• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Cancer Therapeutics

Cancer Therapeutics

  1. Research and Markets: Breast Cancer Therapeutics Pipeline Review, H1 2015 - Features 346 Companies

    Research and Markets: Breast Cancer Therapeutics Pipeline Review, H1 2015 - Features 346 Companies

  2. Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Primary Peritoneal Cancer

    Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Primary Peritoneal Cancer

  3. Halozyme Announces Preclinical Study Results Of PEGPH20 Published In Molecular Cancer Therapeutics

    Halozyme Announces Preclinical Study Results Of PEGPH20 Published In Molecular Cancer Therapeutics

  4. ArQule to Report Fiscal 2014 Financial Results on March 4, 2015

    ArQule to Report Fiscal 2014 Financial Results on March 4, 2015

  5. Bristol-Myers Squibb To Expand Its Immuno-Oncology Pipeline with Agreement to Acquire Flexus Biosciences, Inc.

    Bristol-Myers Squibb To Expand Its Immuno-Oncology Pipeline with Agreement to Acquire Flexus Biosciences, Inc.

  6. Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Pancreatic Cancer

    Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Pancreatic Cancer

  7. Dr. Eric Rowinsky joins Mitra Biotech’s Scientific Advisory Board

    Dr. Eric Rowinsky joins Mitra Biotech’s Scientific Advisory Board

  8. Rosetta Genomics Announces Key Patent Allowances in U.S. and Europe

    Rosetta Genomics Announces Key Patent Allowances in U.S. and Europe

  9. Research and Markets: Metastatic Liver Cancer Pipeline Insights 2014-2015

    Research and Markets: Metastatic Liver Cancer Pipeline Insights 2014-2015

  10. Research and Markets: Metastatic Lung Cancer Pipeline Insights 2015

    Research and Markets: Metastatic Lung Cancer Pipeline Insights 2015

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.